Search - tctmd.com

Displaying 401 - 420 of 448

Sort: Relevancy | Date

News Daily News

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

Jason Kahn

February 28, 2013

News Daily News

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

Jason Kahn

February 28, 2013

News Daily News

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

Caitlin E. Cox

January 30, 2013

News Daily News

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Caitlin E. Cox

January 30, 2013

Presentation

Percutaneous Left Atrial Appendage (LAA) Closure for Stroke Prophylaxis in A-fib Patients

Presenter: Vivek Y. Reddy

January 29, 2013

News Daily News

Un Dispositivo de Atrapamiento para el Cierre del AAI resulta Seguro y Eficaz en un Pequeño Estudio sobre Fibrilación Auricular

L.A. McKeown

January 16, 2013

News Daily News

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

L.A. McKeown

January 16, 2013

Presentation

Initial Experience with a Novel Percutaneous LAA Exclusion Device in Pts with A-fib, Increased Stroke Risk, and Contraindications to Anticoagulation

Presenter: A. Massumi

January 14, 2013

Presentation TCT 2012

Promising LAA Closure Devices and the Structural Heart Team Approach

Presenter: Carlos Pedra

October 25, 2012

Presentation TCT 2012

Transcatheter LAA Occlusion: The Watchman Experience as Proof of Principle

Presenter: David Muller

October 24, 2012

Presentation TCT 2012

Tough Call During an LAA Occlusion

Presenter: Vivek Reddy

October 24, 2012

Presentation TCT 2012

The SentreHeart Transpericardial Approach to LAA Occlusion

Presenter: Steven Yakubov

October 24, 2012

Presentation TCT 2012

Surgical LAA Exclusion: Is It Effective?

Presenter: A. Marc Gillinov

October 24, 2012

Presentation TCT 2012

Next-Generation LAA Occlusion Devices: AMPLATZER (St. Jude Medical) and WAVECREST (Coherex Medical)

Presenter: Horst Sievert

October 24, 2012

Presentation TCT 2012

Various Techniques for Surgical LAA Closure (With and Without Thoracoscopy): Acute and Long-term Outcomes

Presenter: A. Marc Gillinov

October 23, 2012

Presentation TCT 2012

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

Presenter: Peter Block

October 23, 2012

Presentation TCT 2012

The Spectrum of Early Complications of LAA Closure: Have They Been Eliminated?

Presenter: David Holmes Jr

October 23, 2012

Presentation TCT 2012

Synthesis of the New ESC LAA Closure Guidelines

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

Quality-of-Life and Cost-Effectiveness After LAA Closure

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

Lifetech LAA Closure Device: Description and Preclinical Results

Presenter: Yat-Yin Lam

October 23, 2012

Advertisement

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Percutaneous Left Atrial Appendage (LAA) Closure for Stroke Prophylaxis in A-fib Patients

Un Dispositivo de Atrapamiento para el Cierre del AAI resulta Seguro y Eficaz en un Pequeño Estudio sobre Fibrilación Auricular

Snare Device for LAA Closure Safe, Effective in Small A-fib Study

Initial Experience with a Novel Percutaneous LAA Exclusion Device in Pts with A-fib, Increased Stroke Risk, and Contraindications to Anticoagulation

Promising LAA Closure Devices and the Structural Heart Team Approach

Transcatheter LAA Occlusion: The Watchman Experience as Proof of Principle

Tough Call During an LAA Occlusion

The SentreHeart Transpericardial Approach to LAA Occlusion

Surgical LAA Exclusion: Is It Effective?

Next-Generation LAA Occlusion Devices: AMPLATZER (St. Jude Medical) and WAVECREST (Coherex Medical)

Various Techniques for Surgical LAA Closure (With and Without Thoracoscopy): Acute and Long-term Outcomes

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

The Spectrum of Early Complications of LAA Closure: Have They Been Eliminated?

Synthesis of the New ESC LAA Closure Guidelines

Quality-of-Life and Cost-Effectiveness After LAA Closure

Lifetech LAA Closure Device: Description and Preclinical Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content